FDAnews
www.fdanews.com/articles/133690-eu-india-drop-wto-generics-dispute-to-focus-on-fta-talks

EU, India Drop WTO Generics Dispute to Focus on FTA Talks

January 21, 2011
As part of fair trade agreement (FTA) negotiations, the EU and India have unofficially resolved their 2009 World Trade Organization (WTO) dispute over repeated seizures of generic drugs en route from India to other countries. The WTO dispute was initiated by India after the EU repeatedly seized generic drugs originating in India as they passed through European ports on their way to Brazil. The EU made the seizures on grounds of patent infringement, but India disagreed with those claims. Brazil agreed with India and initiated an additional WTO dispute with the EU on the same topic. As a result of India and Brazil’s concerns, the EU is examining its rules that triggered the disputes.
International Pharmaceutical Regulatory Monitor